Cargando…
Open-label Non-blinded Cohort study on Anti-Histaminic Resistant Chronic Idiopathic Urticaria in Western India
INTRODUCTION: Chronic idiopathic urticaria (CIU) is a chronic relapsing disease with hives for a period of six weeks or more. It has a significant impact on the physical and mental well-being of patients. AIMS AND OBJECTIVES: Open-label non-blinded study of over 600 patients diagnosed with CIU was d...
Autores principales: | Natarajan, Subramanian, Subramanian, Poonam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971761/ https://www.ncbi.nlm.nih.gov/pubmed/36865849 http://dx.doi.org/10.4103/ijd.ijd_718_21 |
Ejemplares similares
-
Updosing of Nonsedating Anti-histamines in Recalcitrant Chronic Urticaria
por: Godse, Kiran, et al.
Publicado: (2016) -
Lack of Association of Plasma Histamine with Diamine Oxidase in Chronic Idiopathic Urticaria
por: Cho, Hee Jin, et al.
Publicado: (2013) -
Efficacy and safety of omalizumab in Chinese patients with anti‐histamine refractory chronic spontaneous urticaria
por: Yuan, Weiru, et al.
Publicado: (2022) -
Systematic Review of Excess Mortality in India during the Covid-19 Pandemic with Differentiation between Model-Based and Data-Based Mortality Estimates
por: Natarajan, Subramanian, et al.
Publicado: (2022) -
OLOPATADINE IN CHRONIC IDIOPATHIC URTICARIA
por: Godse, Kiran V
Publicado: (2009)